Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 31451 - 31475 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Cisplatin	Approved Investigational	BCL2	596	downregulated	Cisplatin results in decreased expression of BCL2 mRNA	18q21.33	A22196 A22214 A22219
Cisplatin	Approved Investigational	BCL2	596	downregulated	[Cisplatin results in increased expression of MIR630] which results in decreased expression of BCL2 mRNA	18q21.33	A22223
Cisplatin	Approved Investigational	BCL2A1	597	upregulated	Cisplatin results in increased expression of BCL2A1 mRNA	15q25.1	A22204
Cisplatin	Approved Investigational	BCL2L1	598	downregulated	Cisplatin results in decreased expression of BCL2L1 mRNA	20q11.21	A22224 A22225 A22218
Cisplatin	Approved Investigational	BCL2L11	10018	upregulated	Cisplatin results in increased expression of BCL2L11 mRNA	2q13	A22226
Cisplatin	Approved Investigational	BCL2L12	83596	downregulated	Cisplatin results in decreased expression of BCL2L12 mRNA	19q13.33	A22196
Cisplatin	Approved Investigational	BCL2L2	599	downregulated	[Cisplatin results in increased expression of MIR630] which results in decreased expression of BCL2L2 mRNA	14q11.2	A22223
Cisplatin	Approved Investigational	BCL3	602	upregulated	Cisplatin results in increased expression of BCL3 mRNA	19q13.32	A20427
Cisplatin	Approved Investigational	BCL6	604	upregulated	Cisplatin results in increased expression of BCL6 mRNA	3q27.3	A22212
Cisplatin	Approved Investigational	BEND6	221336	downregulated	Cisplatin results in decreased expression of BEND6 mRNA	6p12.1	A20427
Cisplatin	Approved Investigational	BIK	638	upregulated	Cisplatin results in increased expression of BIK mRNA	22q13.2	A22214
Cisplatin	Approved Investigational	BIRC5	332	downregulated	Cisplatin results in decreased expression of BIRC5 mRNA	17q25.3	A22227 A22228 A22229
Cisplatin	Approved Investigational	BIRC5	332	upregulated	Cisplatin results in increased expression of BIRC5 mRNA	17q25.3	A22230 A22231
Cisplatin	Approved Investigational	BLCAP	10904	upregulated	Cisplatin results in increased expression of BLCAP mRNA	20q11.23	A22204
Cisplatin	Approved Investigational	BLM	641	downregulated	Cisplatin results in decreased expression of BLM mRNA	15q26.1	A21499
Cisplatin	Approved Investigational	BLOC1S2	282991	downregulated	Cisplatin results in decreased expression of BLOC1S2 mRNA	10q24.31	A22204
Cisplatin	Approved Investigational	BMI1	648	upregulated	[Cisplatin results in decreased susceptibility to Cisplatin] which results in increased expression of BMI1 mRNA	10p12.2	A22232
Cisplatin	Approved Investigational	BMP4	652	upregulated	Cisplatin results in increased expression of BMP4 mRNA	14q22.2	A22233
Cisplatin	Approved Investigational	BRCA1	672	upregulated	Cisplatin results in increased expression of BRCA1 mRNA	17q21.31	A22234
Cisplatin	Approved Investigational	BRD2	6046	downregulated	Cisplatin results in decreased expression of BRD2 mRNA	6p21.32	A20427
Cisplatin	Approved Investigational	BRD2	6046	upregulated	Cisplatin results in increased expression of BRD2 mRNA	6p21.32	A22204
Cisplatin	Approved Investigational	BTG1	694	upregulated	Cisplatin results in increased expression of BTG1 mRNA	12q21.33	A22204
Cisplatin	Approved Investigational	BTG2	7832	upregulated	Cisplatin results in increased expression of BTG2 mRNA	1q32.1	A22204 A22212 A22203 A20427
Cisplatin	Approved Investigational	CALB1	793	upregulated	Cisplatin results in increased expression of CALB1 mRNA	8q21.3	A22235
Cisplatin	Approved Investigational	CAMKK2	10645	upregulated	Cisplatin results in increased expression of CAMKK2 mRNA	12q24.31	A20427

Displaying entries 31451 - 31475 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability